Your browser is no longer supported. Please, upgrade your browser.
TRIB Trinity Biotech plc weekly Stock Chart
TRIB [NASD]
Trinity Biotech plc
Index- P/E- EPS (ttm)-1.48 Insider Own11.20% Shs Outstand20.90M Perf Week-6.91%
Market Cap51.41M Forward P/E9.54 EPS next Y0.24 Insider Trans0.00% Shs Float18.99M Perf Month76.15%
Income-31.00M PEG- EPS next Q- Inst Own37.30% Short Float3.68% Perf Quarter160.76%
Sales89.60M P/S0.57 EPS this Y-28.00% Inst Trans-16.41% Short Ratio0.80 Perf Half Y114.02%
Book/sh0.04 P/B57.25 EPS next Y100.00% ROA-20.40% Target Price4.00 Perf Year40.49%
Cash/sh- P/C- EPS next 5Y15.00% ROE-148.20% 52W Range0.56 - 2.66 Perf YTD121.60%
Dividend- P/FCF12.54 EPS past 5Y-33.30% ROI-21.60% 52W High-13.83% Beta1.74
Dividend %- Quick Ratio1.60 Sales past 5Y-2.90% Gross Margin42.50% 52W Low308.20% ATR0.28
Employees579 Current Ratio3.10 Sales Q/Q-3.60% Oper. Margin-29.20% RSI (14)58.07 Volatility17.46% 14.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-954.80% Profit Margin-34.50% Rel Volume1.02 Prev Close2.14
ShortableYes LT Debt/Eq102.75 EarningsMay 27 BMO Payout- Avg Volume877.17K Price2.29
Recom- SMA2012.20% SMA5036.73% SMA20092.94% Volume893,868 Change7.01%
Oct-23-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Initiated Raymond James Outperform
Jul-29-15Reiterated ROTH Capital Buy $22 → $20
Jul-22-08Reiterated Roth Capital Buy $7 → $6
Mar-17-08Reiterated Roth Capital Buy $10.50 → $7
Dec-10-07Reiterated Roth Capital Buy $11.50 → $10.50
Oct-26-07Reiterated Roth Capital Buy $13 → $11.50
Jun-23-20 02:53PM  
Jun-02-20 06:17AM  
May-27-20 10:11AM  
09:00AM  
May-14-20 07:25AM  
Apr-02-20 08:30AM  
Mar-31-20 09:09AM  
09:00AM  
Mar-24-20 10:08AM  
Feb-28-20 12:53PM  
Feb-17-20 02:55PM  
Dec-22-19 05:10PM  
Dec-17-19 09:39AM  
Oct-21-19 03:38PM  
Oct-17-19 07:39AM  
Oct-16-19 08:04AM  
Oct-15-19 11:40AM  
Oct-11-19 12:06PM  
Sep-05-19 08:36AM  
Sep-04-19 07:11PM  
Aug-21-19 07:40AM  
Aug-20-19 08:22AM  
Aug-15-19 02:07PM  
Jul-31-19 08:12AM  
May-15-19 12:13PM  
May-07-19 08:26AM  
May-01-19 10:19AM  
Apr-25-19 04:27PM  
Apr-12-19 11:59AM  
Mar-04-19 05:00AM  
Feb-25-19 02:55PM  
Dec-25-18 12:07PM  
Dec-13-18 01:49AM  
Nov-29-18 08:58AM  
Nov-02-18 03:40PM  
Oct-26-18 09:55PM  
Oct-23-18 08:05AM  
Oct-16-18 05:35AM  
Sep-18-18 09:54AM  
Jul-21-18 08:53AM  
Jul-19-18 08:25AM  
Jul-18-18 04:35PM  
Jul-12-18 10:17AM  
Jun-25-18 02:01PM  
Jun-06-18 08:45AM  
May-22-18 03:13PM  
May-01-18 09:07AM  
Apr-20-18 10:42AM  
Mar-08-18 02:21PM  
Mar-07-18 09:11AM  
08:00AM  
Mar-05-18 08:37AM  
Dec-12-17 12:26PM  
Nov-17-17 06:31AM  
Nov-01-17 09:39AM  
Oct-26-17 08:25AM  
08:00AM  
Oct-13-17 04:54AM  
Aug-12-17 09:16PM  
Aug-10-17 06:37PM  
Jul-26-17 11:43AM  
Jul-20-17 08:28AM  
Jul-03-17 07:57AM  
May-29-17 12:41PM  
May-22-17 06:10PM  
May-03-17 10:06AM  
May-01-17 02:55PM  
12:27PM  
08:05AM  
Apr-27-17 10:15AM  
08:09AM  
Apr-18-17 06:10AM  
Mar-14-17 07:45PM  
09:13AM  
07:07AM  
Mar-01-17 02:34PM  
01:53PM  
Feb-24-17 06:52AM  
Jan-05-17 05:30PM  
Dec-15-16 08:46AM  
Dec-09-16 04:51PM  
Dec-08-16 05:24PM  
Oct-31-16 03:24PM  
Oct-26-16 11:02AM  
Oct-25-16 06:11PM  
09:01AM  
08:15AM  
07:07AM  
Oct-19-16 12:17PM  
Oct-12-16 10:22AM  
05:54AM  
Oct-08-16 09:55AM  
Oct-06-16 06:59PM  
05:24PM  
Oct-05-16 07:19PM  
05:55PM  
05:04PM  
01:28PM  
12:54PM  
12:00PM  
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. The company sells its products through its direct sales force; and a network of independent distributors and strategic partners. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.